Cancel
Brian Blakey
Chief Business Officer
@
Stealth BioTherapeutics
g03qx.p6f4gu@ddppp4zgd.d00
Sign up to see email
Known information
- Has 30 years of pharmaceutical marketing, alliance development, and operations experience.
- Previously served as COO of Element Marketing Group.
- Was Vice President of Commercial Development at Salutria (formerly AtheroGenics).
- Held senior positions at GlaxoSmithKline.
- Holds a Doctor of Pharmacy degree from the University of Florida.
About Stealth BioTherapeutics
Stealth BioTherapeutics develops therapies for mitochondrial dysfunction related to genetic diseases and aging, with a focus on elamipretide and SBT-272 in clinical studies.
Report inaccurate information
